Legislative Affairs

“One of the penalties of not participating in politics is that you will be governed by your inferiors.”

Plato

The mission of APCI’s Legislative Affairs division is to promote and protect the political and economic interests of all APCI members. In order to accomplish that mission, Legislative Affairs:

  • Provides lobbyist and/or legislative assistance in all APCI member states
  • Identifies pharmacy-friendly political candidates and generate funding to support them
  • Contributes to state associations and organizations with similar legislative focus
  • Identifies political leaders to meet and key meetings or conferences to attend
  • Establishes routine and structured legislative meetings in each state
  • Leverages APCI account representatives and staff personnel
  • Utilizes APCI's Board of Directors to attend selected legislative events
  • Encourages APCI member participation and support of NCPA
  • Maintains a Washington, D.C., presence, supporting NCPA and developing direct relationships

For more information about APCI's Legistative Affairs division, contact us or call (800) 532-2724.

2

Nov

2015

NCPA Advocacy Center Update 11.2.15

This week's Advocacy Update includes news on Paul Ryan's election as Speaker of the House of Representatives, another DSCSA enforcement delay, concerns about the Walgreens / Rite-Aid merger, and much more!

19

Oct

2015

NCPA Advocacy Center Update 10.19.15

In this week's Advocacy Update, NCPA reports on PAC fundraising, a move for CMS to finalize DIR guidance, TRICARE mail order requirements, and more!

5

Oct

2015

NCPA Advocacy Center Update 10.5.15

This week's Advocacy Center Update includes information on TRICARE, Medicare Part D, FDA meetings, and clozapine.

28

Sep

2015

NCPA Advocacy Center Update 9.28.15

This week's Advocacy Center update looks at John Boehner's retirement, TRICARE changes, the 2016 Part D landscape, and more!

24

Sep

2015

TRICARE Brand Name Rx Changes Effective Oct. 1.

Reminder: TRICARE Brand Name Rx Changes Coming Oct. 1: Please let your patients know this impacts select brand name maintenance drugs only!

First 68697071 Last